Gladstone Institutional Advisory LLC Raises Stake in Colgate-Palmolive (NYSE:CL)

Gladstone Institutional Advisory LLC grew its holdings in Colgate-Palmolive (NYSE:CL) by 10.3% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 6,758 shares of the company’s stock after purchasing an additional 631 shares during the quarter. Gladstone Institutional Advisory LLC’s holdings in Colgate-Palmolive were worth $702,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of CL. E Fund Management Hong Kong Co. Ltd. acquired a new stake in Colgate-Palmolive during the 2nd quarter worth $25,000. Continuum Advisory LLC grew its position in Colgate-Palmolive by 46.5% in the 2nd quarter. Continuum Advisory LLC now owns 394 shares of the company’s stock valued at $38,000 after acquiring an additional 125 shares in the last quarter. Reston Wealth Management LLC purchased a new stake in Colgate-Palmolive during the third quarter worth about $42,000. Gradient Investments LLC lifted its position in shares of Colgate-Palmolive by 150.4% during the second quarter. Gradient Investments LLC now owns 666 shares of the company’s stock worth $65,000 after purchasing an additional 400 shares in the last quarter. Finally, Financial Connections Group Inc. acquired a new position in shares of Colgate-Palmolive in the second quarter valued at approximately $68,000. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on CL shares. JPMorgan Chase & Co. boosted their target price on shares of Colgate-Palmolive from $113.00 to $114.00 and gave the stock an “overweight” rating in a research note on Friday, October 11th. Redburn Atlantic upgraded Colgate-Palmolive to a “hold” rating in a research note on Thursday, August 1st. Piper Sandler assumed coverage on Colgate-Palmolive in a research note on Tuesday, September 24th. They issued an “overweight” rating and a $121.00 target price on the stock. StockNews.com downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Tuesday, October 29th. Finally, Sanford C. Bernstein boosted their target price on Colgate-Palmolive from $100.00 to $103.00 and gave the stock a “market perform” rating in a research report on Tuesday, July 30th. One analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have issued a buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $105.11.

Colgate-Palmolive Price Performance

NYSE:CL opened at $93.33 on Monday. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.28. Colgate-Palmolive has a one year low of $74.22 and a one year high of $109.30. The company has a fifty day moving average price of $102.26 and a 200 day moving average price of $98.35. The stock has a market cap of $76.25 billion, a P/E ratio of 26.74, a PEG ratio of 3.35 and a beta of 0.42.

Colgate-Palmolive Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be issued a $0.50 dividend. The ex-dividend date of this dividend is Friday, October 18th. This represents a $2.00 annualized dividend and a yield of 2.14%. Colgate-Palmolive’s dividend payout ratio (DPR) is 57.31%.

Insider Activity at Colgate-Palmolive

In other Colgate-Palmolive news, insider Panagiotis Tsourapas sold 14,794 shares of the company’s stock in a transaction dated Thursday, August 8th. The shares were sold at an average price of $102.94, for a total transaction of $1,522,894.36. Following the sale, the insider now directly owns 5,146 shares of the company’s stock, valued at approximately $529,729.24. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In other Colgate-Palmolive news, insider Panagiotis Tsourapas sold 14,794 shares of Colgate-Palmolive stock in a transaction on Thursday, August 8th. The shares were sold at an average price of $102.94, for a total transaction of $1,522,894.36. Following the completion of the sale, the insider now owns 5,146 shares of the company’s stock, valued at approximately $529,729.24. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Martina Hundmejean sold 2,313 shares of the stock in a transaction on Friday, August 23rd. The shares were sold at an average price of $103.86, for a total value of $240,228.18. Following the completion of the transaction, the director now directly owns 11,755 shares in the company, valued at approximately $1,220,874.30. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 43,490 shares of company stock worth $4,486,063. 0.34% of the stock is owned by corporate insiders.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.